Top Markets
Coin of the day
Palvella Therapeutics, Inc. Palvella Therapeutics, Inc.

Palvella Therapeutics, Inc.

PVLA
Kedudukan dalam Saham #6083
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company... Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic malformations. Additionally, this drug is in Phase 2 evaluation for treating cutaneous venous malformations. Beyond these specific indications, Palvella is also advancing QTORIN rapamycin for the treatment of other dermatological diseases driven by the mTOR pathway. The company's headquarters are situated in Wayne, Pennsylvania.
Harga Saham
$153.90
Modal Pasaran
$2.21B
Perubahan (1 hari)
-0.28%
Perubahan (1 tahun)
172.63%
Negara
US
Perdagangan Palvella Therapeutics, Inc. (PVLA)

Kategori

Sejarah pecahan saham untuk Palvella Therapeutics, Inc. (PVLA)
Saham Palvella Therapeutics, Inc. (simbol: PVLA) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 27, 2026.
Satu saham PVLA yang dibeli sebelum Aug 27, 2026 kini bersamaan dengan 0 saham PVLA.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH